Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | DNTH | ERAS | ||
| Company | Eidos Therapeutics Inc | Dianthus Therapeutics Inc | Erasca Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 127.57 | 86.41 | 14.84 | ||
| High | 128.49 | 88.97 | 15.75 | ||
| Low | 116.83 | 84.61 | 14.76 | ||
| Latest | 122.21 | 87.09 | 15.14 | ||
| Change | -6.23 | -0.28 | +0.06 | ||
| % Change | -4.85% | -0.32% | +0.40% | ||
| Volume | 335,500 | 385,505 | 2,383,936 | ||
| 20-Day Average Volume | 113,985 | 1,111,878 | 5,529,551 | ||
| Previous Close | 128.44 | 87.37 | 15.08 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 83.96 | 13.41 | ||
| 20-Day Raw Stochastic | 36.63% | 74.78% | 91.38% | ||
| 20-Day Relative Strength | 56.42 | 53.70 | 58.14 | ||
| Weighted Alpha | +136.62 | +293.62 | +992.75 | ||
| Today's Opinion | 88% Buy | 72% Buy | 56% Buy | ||
| Previous Opinion | 100% Buy | 72% Buy | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | +5.88% since 06/15/26 | +5.86% since 06/15/26 | ||
| Low | 116.83 on 01/25/21 | 77.61 on 06/16/26 | 13.32 on 06/16/26 | ||
| High | 131.08 on 01/20/21 | 88.97 on 06/23/26 | 15.69 on 06/23/26 | ||
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | +1.02% since 05/22/26 | +35.90% since 05/22/26 | ||
| Low | 116.24 on 01/05/21 | 68.85 on 06/10/26 | 10.93 on 05/26/26 | ||
| High | 132.54 on 01/04/21 | 93.61 on 05/29/26 | 15.69 on 06/23/26 | ||
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | +10.14% since 03/23/26 | +6.67% since 03/23/26 | ||
| Low | 69.38 on 10/30/20 | 68.85 on 06/10/26 | 8.70 on 04/28/26 | ||
| High | 132.54 on 01/04/21 | 96.50 on 04/16/26 | 24.28 on 04/23/26 | ||
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | +105.03% since 12/23/25 | +350.59% since 12/23/25 | ||
| Low | 38.44 on 07/31/20 | 35.84 on 01/06/26 | 3.36 on 12/26/25 | ||
| High | 132.54 on 01/04/21 | 96.50 on 04/16/26 | 24.28 on 04/23/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 4,776,169 | 4,689,654 | ||
| Shares Outstanding, K | 38,873 | 54,666 | 310,985 | ||
| Annual Sales | 26,690,000 | 2,040,000 | 0 | ||
| Annual Net Income | -37,840,000 | -162,340,000 | -124,550,000 | ||
| Last Quarter Sales | 130,000 | 460,000 | 0 | ||
| Last Quarter Net Income | -30,180,000 | -40,830,000 | -183,440,000 | ||
| 60-Month Beta | -0.16 | 1.18 | 0.73 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.85 on 05/05/26 | -0.11 on 05/11/26 | ||
| Earnings Date | 02/24/21 | 08/06/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||